These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 31200666)

  • 1. A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential.
    Gobin E; Bagwell K; Wagner J; Mysona D; Sandirasegarane S; Smith N; Bai S; Sharma A; Schleifer R; She JX
    BMC Cancer; 2019 Jun; 19(1):581. PubMed ID: 31200666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma.
    Liu M; Huang L; Liu Y; Yang S; Rao Y; Chen X; Nie M; Liu X
    J Transl Med; 2023 Mar; 21(1):208. PubMed ID: 36941602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer.
    Geng X; Chen C; Huang Y; Hou J
    Int J Med Sci; 2020; 17(11):1550-1560. PubMed ID: 32669958
    [No Abstract]   [Full Text] [Related]  

  • 4. Comprehensive Analysis of the Expression and Prognosis for MMPs in Human Colorectal Cancer.
    Yu J; He Z; He X; Luo Z; Lian L; Wu B; Lan P; Chen H
    Front Oncol; 2021; 11():771099. PubMed ID: 34804973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential diagnostic biomarkers in MMPs for pancreatic carcinoma.
    Xie J; Zhou X; Wang R; Zhao J; Tang J; Zhang Q; Du Y; Pang Y
    Medicine (Baltimore); 2021 Jun; 100(23):e26135. PubMed ID: 34114996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC).
    Li K; Li D; Hafez B; Bekhit MMS; Jardan YAB; Alanazi FK; Taha EI; Auda SH; Ramzan F; Jamil M
    Oncol Res; 2024; 32(4):737-752. PubMed ID: 38560573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Landscape Analysis of Matrix Metalloproteinases Unveils Key Prognostic Markers for Patients With Breast Cancer.
    Cheng T; Chen P; Chen J; Deng Y; Huang C
    Front Genet; 2021; 12():809600. PubMed ID: 35069702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
    Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
    Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma.
    Wang T; Zhang Y; Bai J; Xue Y; Peng Q
    BMC Cancer; 2021 Sep; 21(1):1068. PubMed ID: 34587931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-Like Receptor 4 and Matrix Metalloproteases 11 and 13 as Predictors of Tumor Recurrence and Survival in Stage II Colorectal Cancer.
    Eiro N; Carrión JF; Cid S; Andicoechea A; García-Muñiz JL; González LO; Vizoso FJ
    Pathol Oncol Res; 2019 Oct; 25(4):1589-1597. PubMed ID: 30710321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
    Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
    BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
    Pietruszewska W; Bojanowska-Poźniak K; Kobos J
    Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New signaling pathways from cancer progression modulators to mRNA expression of matrix metalloproteinases in breast cancer cells.
    Delassus GS; Cho H; Eliceiri GL
    J Cell Physiol; 2011 Dec; 226(12):3378-84. PubMed ID: 21344390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.
    Fernandez-Garcia B; Eiró N; Marín L; González-Reyes S; González LO; Lamelas ML; Vizoso FJ
    Histopathology; 2014 Mar; 64(4):512-22. PubMed ID: 24117661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative gene expression profile of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure requiring left ventricular assist device support.
    Felkin LE; Birks EJ; George R; Wong S; Khaghani A; Yacoub MH; Barton PJ
    J Heart Lung Transplant; 2006 Dec; 25(12):1413-9. PubMed ID: 17178334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer.
    Luan H; Jian L; Huang Y; Guo Y; Zhou L
    Sci Rep; 2023 Oct; 13(1):17211. PubMed ID: 37821678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of matrix metalloproteinases mediates thromboxane A2-induced invasion in lung cancer cells.
    Li X; Tai HH
    Curr Cancer Drug Targets; 2012 Jul; 12(6):703-15. PubMed ID: 22515524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
    PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma.
    Cho NH; Shim HS; Rha SY; Kang SH; Hong SH; Choi YD; Hong SJ; Cho SH
    Eur Urol; 2003 Nov; 44(5):560-6. PubMed ID: 14572755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.